Ishita Drugs and Industries Limited (BOM:524400)

Market Cap	206.66M -5.0%
Revenue (ttm)	161.68M +8.3%
Net Income	8.89M +3.1%
EPS	2.97 +3.1%
Shares Out	2.99M
PE Ratio	23.27
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	637
Average Volume	2,656
Open	72.90
Previous Close	77.89
Day's Range	68.21 - 72.90
52-Week Range	66.00 - 90.85
Beta	-0.58
RSI	43.75
Earnings Date	May 26, 2026

About BOM:524400

Ishita Drugs and Industries Limited manufactures and sells active pharma ingredients (APIs), fine chemicals, drug intermediates, and excipients in India and internationally. The company offers APIs, such as sulfa drugs/sulfonamides, vitamins, fluoro quinolones, antibiotics, anthelmintics, iodides and citrates, food additives/excipients, and others. It also provides contract manufacturing services for various drug intermediates, fine chemicals, or specialty chemicals. Ishita Drugs and Industries Limited was incorporated in 1992 and is based in A...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1992
• Employees: 14
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 524400

Financial Performance

In fiscal year 2025, BOM:524400's revenue was 149.97 million, a decrease of -1.25% compared to the previous year's 151.88 million. Earnings were 8.68 million, an increase of 15.98%.